BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19587537)

  • 1. MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients.
    Pantano F; Baldi A; Santini D; Vincenzi B; Borzomati D; Vecchio FM; Castri F; Antinori A; Caraglia M; Magistrelli P; Coppola R; Tonini G
    Cancer Biol Ther; 2009 Jun; 8(11):996-9. PubMed ID: 19587537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUC2: a new key for pancreas cancer prognosis.
    Addeo R; Abbruzzese A; Del Prete S
    Cancer Biol Ther; 2009 Jun; 8(11):1000-1. PubMed ID: 19587529
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of MUC apomucins in normal pancreas and pancreatic tumours.
    Terada T; Ohta T; Sasaki M; Nakanuma Y; Kim YS
    J Pathol; 1996 Oct; 180(2):160-5. PubMed ID: 8976874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.
    Tonini G; Vincenzi B; Santini D; Scarpa S; Vasaturo T; Malacrino C; Coppola R; Magistrelli P; Borzomati D; Baldi A; Antinori A; Caricato M; Nuzzo G; Picciocchi A
    Br J Cancer; 2005 Jun; 92(12):2225-32. PubMed ID: 15928668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival.
    Hiraki T; Yamada S; Higashi M; Hatanaka K; Yokoyama S; Kitazono I; Goto Y; Kirishima M; Batra SK; Yonezawa S; Tanimoto A
    Histol Histopathol; 2017 Jun; 32(6):585-596. PubMed ID: 27672051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma.
    Lüttges J; Zamboni G; Longnecker D; Klöppel G
    Am J Surg Pathol; 2001 Jul; 25(7):942-8. PubMed ID: 11420467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance.
    Sierzega M; Młynarski D; Tomaszewska R; Kulig J
    Histopathology; 2016 Oct; 69(4):582-91. PubMed ID: 27165582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines.
    Balagué C; Gambús G; Carrato C; Porchet N; Aubert JP; Kim YS; Real FX
    Gastroenterology; 1994 Apr; 106(4):1054-61. PubMed ID: 8143972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
    Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
    Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma.
    Santini D; Baldi A; Vincenzi B; Mellone P; Campioni M; Antinori A; Borzomati D; Coppola R; Magistrelli P; Tonini G
    J Clin Pathol; 2007 Sep; 60(9):1069-70. PubMed ID: 17761747
    [No Abstract]   [Full Text] [Related]  

  • 11. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma.
    Seeliger H; Pozios I; Assmann G; Zhao Y; Müller MH; Knösel T; Kreis ME; Bruns CJ
    BMC Cancer; 2018 Oct; 18(1):1049. PubMed ID: 30373552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma.
    Qian Y; Gong Y; Liu Y; Chen Y; Wang R; Dai Z; Zou X; Tasiheng Y; Luo G; Lin X; Wang X; Cheng H; Yu X; Liu C
    J Immunol Res; 2022; 2022():7353572. PubMed ID: 35910854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients.
    Yonezawa S; Sueyoshi K; Nomoto M; Kitamura H; Nagata K; Arimura Y; Tanaka S; Hollingsworth MA; Siddiki B; Kim YS; Sato E
    Hum Pathol; 1997 Mar; 28(3):344-52. PubMed ID: 9042800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression.
    Kang H; An HJ; Song JY; Kim TH; Heo JH; Ahn DH; Kim G
    Histopathology; 2012 Oct; 61(4):576-86. PubMed ID: 22691042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.
    Qi W; Shao F; Huang Q
    Med Sci Monit; 2017 Dec; 23():6012-6018. PubMed ID: 29257799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
    Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
    Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of mucin expression in pancreatobiliary neoplasms.
    Yonezawa S; Higashi M; Yamada N; Yokoyama S; Goto M
    J Hepatobiliary Pancreat Sci; 2010 Mar; 17(2):108-24. PubMed ID: 19787286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
    Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A
    J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of YKL-40 Predicts Poor Prognosis in Patients Undergoing Curative Resection of Pancreatic Cancer.
    Chen HT; Zheng JM; Zhang YZ; Yang M; Wang YL; Man XH; Chen Y; Cai QC; Li ZS
    Pancreas; 2017 Mar; 46(3):323-334. PubMed ID: 28099248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.